SCHEMBL26429014

SCHEMBL26429014

O=C(ON1Cc2nccnc2C1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.42
F2 P00734 1/20 0.42
TSHR P16473 4/20 0.40
KMT2A Q03164 4/20 0.39
MAPT P10636 1/20 0.39
MEN1 O00255 2/20 0.39
CHRNA7 P36544 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
HTR3E A5X5Y0 1/20 0.38
HTR3B O95264 1/20 0.38
HTR3A P46098 1/20 0.38
HTR3D Q70Z44 1/20 0.38
HTR3C Q8WXA8 1/20 0.38
METAP2 P50579 1/20 0.38
METAP1 P53582 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
MITF O75030 1/20 0.38
PKM P14618 1/20 0.38
CDK5 Q00535 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26429016 0.81 LMNA (0.35) LMNAF2TSHRKMT2AMAPT
SCHEMBL26429018 0.79 NPSR1 (0.34) LMNAF2TSHRKMT2AMAPT
SCHEMBL26429017 0.78 NPSR1 (0.33) LMNAF2TSHRKMT2AMAPT
SCHEMBL25771035 0.77 LMNA (0.47) LMNAF2TSHRKMT2AMAPT
SCHEMBL25690687 0.76 ABHD6 (0.44) LMNAF2KMT2AMAPTMEN1
SCHEMBL20004202 0.73 LMNA (0.39) LMNAF2TSHRKMT2AMAPT
SCHEMBL2510973 0.73 KMT2A (0.50) LMNAF2TSHRKMT2AMAPT
SCHEMBL25939713 0.73 LMNA (0.50) LMNAF2TSHRKMT2AMAPT
SCHEMBL25770782 0.72 F2 (0.41) LMNAF2TSHRKMT2AMAPT
SCHEMBL1249246 0.72 HPGD (0.53) LMNAF2TSHRKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023067353-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER ARTIOS PHARMA LIMITED (GB) 2023-04-27 WO disclosed